SG11201505853RA - Stable compositions comprising heparinoid, acute-acting anesthetic, and buffer - Google Patents
Stable compositions comprising heparinoid, acute-acting anesthetic, and bufferInfo
- Publication number
- SG11201505853RA SG11201505853RA SG11201505853RA SG11201505853RA SG11201505853RA SG 11201505853R A SG11201505853R A SG 11201505853RA SG 11201505853R A SG11201505853R A SG 11201505853RA SG 11201505853R A SG11201505853R A SG 11201505853RA SG 11201505853R A SG11201505853R A SG 11201505853RA
- Authority
- SG
- Singapore
- Prior art keywords
- heparinoid
- acute
- buffer
- stable compositions
- acting anesthetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Anesthesiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361757592P | 2013-01-28 | 2013-01-28 | |
| PCT/US2014/013352 WO2014171986A1 (en) | 2013-01-28 | 2014-01-28 | Stable compositions comprising heparinoid, acute-acting anesthetic, and buffer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201505853RA true SG11201505853RA (en) | 2015-08-28 |
Family
ID=51731742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201505853RA SG11201505853RA (en) | 2013-01-28 | 2014-01-28 | Stable compositions comprising heparinoid, acute-acting anesthetic, and buffer |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20150359816A1 (en) |
| EP (1) | EP2948154A4 (en) |
| JP (2) | JP2016517390A (en) |
| KR (1) | KR20160008496A (en) |
| CN (1) | CN105263503A (en) |
| AU (2) | AU2014254472A1 (en) |
| BR (1) | BR112015018047A8 (en) |
| CA (1) | CA2899636C (en) |
| IL (1) | IL240194B (en) |
| MX (1) | MX2015009696A (en) |
| SG (1) | SG11201505853RA (en) |
| WO (1) | WO2014171986A1 (en) |
| ZA (1) | ZA201505814B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10117847B2 (en) | 2015-12-04 | 2018-11-06 | Ventis Pharma | Extended duration local anesthetic formulation |
| US11491179B2 (en) | 2017-04-12 | 2022-11-08 | Urigen Pharmaceuticals, Inc. | Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability |
| EP3400951B1 (en) * | 2017-05-12 | 2019-12-11 | Farco-Pharma GmbH | Bladder instillation composition containing chondoitin sulfate (4,5 mg/ml), hyaluronic acid (16 mg/ml) and phosphate buffer (ph 6,1 to 7,9) with an improved storage stability for the treatment of cystitis |
| EP3415163B1 (en) * | 2017-06-13 | 2023-02-22 | Farco-Pharma GmbH | Composition with topical anaesthetic effect and the use thereof |
| KR102385760B1 (en) * | 2019-04-26 | 2022-04-11 | 티씨엠 바이오테크 인터내셔널 코포레이션 | Pharmaceutical composition for the prevention of recurrent urinary tract infection |
| AU2020315353A1 (en) * | 2019-07-18 | 2022-03-10 | C. Lowell Parsons | Alkalization of urinary bladder wall prior to treatment with intravesical heparin and alkalinized lidocaine to enhance relief of bladder pain symptoms |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5603695A (en) * | 1995-06-07 | 1997-02-18 | Erickson; Kim | Device for alkalizing local anesthetic injection medication |
| EP1708722B1 (en) * | 2004-01-28 | 2014-05-21 | The Regents of The University of California | Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis |
| KR20140002082A (en) * | 2005-01-14 | 2014-01-07 | 유리젠, 인코포레이티드 | Kits and improved compositions for treating lower urinary tract disorders |
| WO2007073397A1 (en) * | 2005-12-19 | 2007-06-28 | Urigen, Inc. | Kits and improved compositions for treating lower urinary tract discorders |
| US8357795B2 (en) * | 2008-08-04 | 2013-01-22 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
| WO2011019963A2 (en) * | 2009-08-13 | 2011-02-17 | Singularis, Inc. | Prg4 treatment for interstitial cystitis |
| CN110292639A (en) * | 2011-01-06 | 2019-10-01 | C·洛维尔·帕森斯 | The method of composition of the manufacture comprising local anesthetic, heparan and buffer |
| US9486747B2 (en) * | 2014-08-12 | 2016-11-08 | The Curators Of The University Of Missouri | Nanocomposite membranes with advanced antifouling properties under visible light irradiation |
-
2014
- 2014-01-28 AU AU2014254472A patent/AU2014254472A1/en not_active Abandoned
- 2014-01-28 BR BR112015018047A patent/BR112015018047A8/en not_active Application Discontinuation
- 2014-01-28 CN CN201480018245.5A patent/CN105263503A/en active Pending
- 2014-01-28 MX MX2015009696A patent/MX2015009696A/en unknown
- 2014-01-28 SG SG11201505853RA patent/SG11201505853RA/en unknown
- 2014-01-28 JP JP2015555403A patent/JP2016517390A/en active Pending
- 2014-01-28 CA CA2899636A patent/CA2899636C/en active Active
- 2014-01-28 WO PCT/US2014/013352 patent/WO2014171986A1/en active Application Filing
- 2014-01-28 US US14/763,369 patent/US20150359816A1/en active Pending
- 2014-01-28 EP EP14785471.5A patent/EP2948154A4/en active Pending
- 2014-01-28 KR KR1020157023381A patent/KR20160008496A/en not_active Application Discontinuation
-
2015
- 2015-07-28 IL IL240194A patent/IL240194B/en unknown
- 2015-08-13 ZA ZA2015/05814A patent/ZA201505814B/en unknown
-
2018
- 2018-08-13 JP JP2018152223A patent/JP2019006783A/en active Pending
- 2018-10-11 AU AU2018247284A patent/AU2018247284A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2015009696A (en) | 2016-03-31 |
| KR20160008496A (en) | 2016-01-22 |
| BR112015018047A8 (en) | 2019-11-05 |
| JP2016517390A (en) | 2016-06-16 |
| AU2014254472A1 (en) | 2015-08-20 |
| IL240194B (en) | 2021-12-01 |
| JP2019006783A (en) | 2019-01-17 |
| BR112015018047A2 (en) | 2017-07-18 |
| AU2018247284A1 (en) | 2018-11-01 |
| CA2899636A1 (en) | 2014-10-23 |
| IL240194A0 (en) | 2015-09-24 |
| US20150359816A1 (en) | 2015-12-17 |
| CA2899636C (en) | 2021-05-25 |
| WO2014171986A1 (en) | 2014-10-23 |
| CN105263503A (en) | 2016-01-20 |
| EP2948154A4 (en) | 2016-09-14 |
| EP2948154A1 (en) | 2015-12-02 |
| ZA201505814B (en) | 2016-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1223975A1 (en) | Nanobubble-containing composition and use thereof | |
| IL244877A0 (en) | High performance compositions and composites | |
| IL244850A0 (en) | Stabilized efinaconazole compositions and uses thereof | |
| HK1215595A1 (en) | Interleukin-10 compositions and uses thereof -10 | |
| ZA201602510B (en) | Strigolactone formulations and uses thereof | |
| EP2968304A4 (en) | 4-phenylpiperidines, their preparation and use | |
| GB201317286D0 (en) | Composition and Use | |
| EP2968303A4 (en) | Octahydrocyclopentapyrroles, their preparation and use | |
| IL241355B (en) | Pyrazole-amide compounds, compositions comprising same and uses yhereof | |
| GB201314312D0 (en) | Composition and delivery system | |
| HK1222563A1 (en) | Pharmaceutical composition, preparation and uses thereof | |
| GB201321693D0 (en) | Composition and uses thereof | |
| EP3012292A4 (en) | Processing aid, and composition | |
| IL276126B (en) | Compositions comprising l-4-chlorokynurenine and uses thereof | |
| ZA201505814B (en) | Stable compositions comprising heparinoid, acute-acting anesthetic, and buffer | |
| EP2953455A4 (en) | Antimicrobial compositions, wipes, and methods | |
| EP3007720A4 (en) | Compositions comprising gc- macrophage activating factor and uses thereof | |
| HK1213800A1 (en) | Toxoid, compositions and related methods | |
| EP2964610A4 (en) | Vinylsulfone-based 18f-labeling compositions and methods and uses thereof | |
| GB2516838B (en) | Fungicidal compositions and their use | |
| HUE037525T2 (en) | Snorna, compositions and uses | |
| GB201301979D0 (en) | New composition and use thereof | |
| HK1213917A1 (en) | Toxoid, compositions and related methods | |
| EP3080142A4 (en) | Glycopeptide compositions and uses thereof | |
| IL284405A (en) | Pharmaceutical composition, preparation and uses thereof |